Shanghai HeartCare Medical Technology Management
Management criteria checks 4/4
Shanghai HeartCare Medical Technology's CEO is Guohui Wang, appointed in Jun 2016, has a tenure of 8.42 years. total yearly compensation is CN¥1.17M, comprised of 68.3% salary and 31.7% bonuses, including company stock and options. directly owns 10.05% of the company’s shares, worth HK$81.99M. The average tenure of the management team and the board of directors is 4 years and 3.1 years respectively.
Key information
Guohui Wang
Chief executive officer
CN¥1.2m
Total compensation
| CEO salary percentage | 68.3% |
| CEO tenure | 8.4yrs |
| CEO ownership | 10.0% |
| Management average tenure | 4yrs |
| Board average tenure | 3.1yrs |
Recent management updates
Recent updates
Even With A 42% Surge, Cautious Investors Are Not Rewarding Shanghai HeartCare Medical Technology Corporation Limited's (HKG:6609) Performance Completely
Sep 27
Some Shareholders Feeling Restless Over Shanghai HeartCare Medical Technology Corporation Limited's (HKG:6609) P/S Ratio
Aug 01We're Not Very Worried About Shanghai HeartCare Medical Technology's (HKG:6609) Cash Burn Rate
Jan 23Shanghai HeartCare Medical Technology Corporation Limited (HKG:6609) Shares May Have Slumped 27% But Getting In Cheap Is Still Unlikely
Aug 30Companies Like Shanghai HeartCare Medical Technology (HKG:6609) Are In A Position To Invest In Growth
Aug 09Companies Like Shanghai HeartCare Medical Technology (HKG:6609) Are In A Position To Invest In Growth
May 07We're Hopeful That Shanghai HeartCare Medical Technology (HKG:6609) Will Use Its Cash Wisely
Nov 29CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | -CN¥45m |
| Mar 31 2024 | n/a | n/a | -CN¥69m |
| Dec 31 2023 | CN¥1m | CN¥799k | -CN¥94m |
| Sep 30 2023 | n/a | n/a | -CN¥141m |
| Jun 30 2023 | n/a | n/a | -CN¥188m |
| Mar 31 2023 | n/a | n/a | -CN¥194m |
| Dec 31 2022 | CN¥1m | CN¥1m | -CN¥200m |
| Sep 30 2022 | n/a | n/a | -CN¥185m |
| Jun 30 2022 | n/a | n/a | -CN¥169m |
| Mar 31 2022 | n/a | n/a | -CN¥188m |
| Dec 31 2021 | CN¥21m | CN¥1m | -CN¥194m |
| Sep 30 2021 | n/a | n/a | -CN¥242m |
| Jun 30 2021 | n/a | n/a | -CN¥290m |
| Mar 31 2021 | n/a | n/a | -CN¥244m |
| Dec 31 2020 | CN¥82m | CN¥771k | -CN¥214m |
Compensation vs Market: Guohui's total compensation ($USD161.34K) is below average for companies of similar size in the Hong Kong market ($USD232.96K).
Compensation vs Earnings: Guohui's compensation has been consistent with company performance over the past year.
CEO
Guohui Wang (46 yo)
8.4yrs
Tenure
CN¥1,169,000
Compensation
Mr. Guohui Wang is the Chief Executive Officer and Director of Shanghai HeartCare Medical Technology Corporation Limited since June 2016 and serves as its Chairman since November 23, 2020. He served as the...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman & CEO | 8.4yrs | CN¥1.17m | 10.05% HK$ 82.0m | |
| Deputy GM & Executive Director | 4yrs | CN¥1.07m | 3.66% HK$ 29.8m | |
| Deputy GM & Executive Director | 4yrs | CN¥3.47m | no data | |
| CFO & Joint Company Secretary | 4yrs | no data | no data | |
| VP of Quality Regulation & Employee Representative Supervisor | no data | no data | no data | |
| Joint Company Secretary | 2.7yrs | no data | no data |
4.0yrs
Average Tenure
43yo
Average Age
Experienced Management: 6609's management team is considered experienced (4 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman & CEO | 8.4yrs | CN¥1.17m | 10.05% HK$ 82.0m | |
| Deputy GM & Executive Director | 4yrs | CN¥1.07m | 3.66% HK$ 29.8m | |
| Deputy GM & Executive Director | 2.4yrs | CN¥3.47m | no data | |
| VP of Quality Regulation & Employee Representative Supervisor | less than a year | no data | no data | |
| Independent Non-Executive Director | 4yrs | CN¥235.00k | no data | |
| Non-Executive Director | less than a year | no data | no data | |
| Non-Executive Director | 4yrs | no data | 4.11% HK$ 33.5m | |
| Independent Non-Executive Director | 4yrs | CN¥30.00k | no data | |
| Independent Non-Executive Director | 3.8yrs | CN¥200.00k | no data | |
| Non-Executive Director | 2yrs | CN¥120.00k | no data | |
| Supervisor | 2yrs | no data | no data | |
| Supervisor | 2yrs | no data | no data |
3.1yrs
Average Tenure
41yo
Average Age
Experienced Board: 6609's board of directors are considered experienced (3.1 years average tenure).